Pharma Market Research | Managed Care, Drug Launch and Healthcare Research

Access Answered.

Welcome to Zitter Health Insights, formerly known as The Zitter Group, the healthcare industry’s leading source for insights into payer influence on the use of medical therapies and technologies.
Learn More
“Will payers change their reimbursement practices for our infused/injected agent when a competitor’s oral product is launched in 6 months?”
Get Our Insights
“We are launching a molecule in a therapeutic indication that my company has limited experience with; how can I get up to speed on payer approaches and access requirements?”
Learn More
How will P&T committees respond to our pivotal clinical trial data?
Learn More

Did You Know....

Patients report that they will stop filling prescriptions at an average
co-pay of $215?

Learn More
Do you have granular insights into WHY patients choose, adopt, and adhere?

Learn More
Did You Know...

21% of patients ask for a specific medicine when the doctor writes a prescription. In 92% of the cases, the doctor prescribed what the patient requested.
Learn More

Did You Know...

Gilead Sciences had the greatest increase in share of voice with payers over the past 6 months

How Does Yours Compare?
Did You Know...

...nearly 60% of payers have adopted clinical pathway programs in prostate cancer, a significant increase over the past year

Learn More
Did You Know...

nearly 43% of RA patients do not use co-pay programs because they do not find the program benefit to be rich enough

Learn More

PA Snapshot:

BCBS Alabama removed a biologic step for Tecfidera in January

Learn More
Payers Indicate

That the SVR rate is the most important characteristic when evaluating regimens to treat Hepatitis C; side effect profile is the second most important characteristic

Learn More
Did You Know...

When writing a prescription, the doctor initiates discussion about drug costs in 54% of the cases?

Learn More

Did You Know

Payers indicate that Hepatitis C, Crohn’s disease, PSO, PAH, Osteoporosis and AMD have significantly increased in management priority since Fall 2013

Find Out
Did You Know....

Prostate cancer has experienced a recent significant increase in clinical pathway adoption

Learn More
Did You Know...

Only 13% of brands with a co-pay offset program are brands that have a direct generic available

Learn more

Did You Know...

… although payers grant high importance to HCV adherence programs, only 41% have an HCV specific program in place

Learn More
Did You Know...

half of payers believe biosimilars will have an impact on management of specialty categories within the next two years

Learn More
Upcoming P&T Perspective Sessions 2014:

September 2014: SOLD OUT

December 2014 (5 sessions): Limited availability

Learn More

Patients’ Feelings upon Receiving a New Script Are Related to Whether the Doctor Included Their Opinion about Treatment Options
Read More »
Some HCV Patients Get More Time with Their Doctor than Others
Read More »

Zitter Health Insights Access Answered.